PDF(Pubmed)
Abstract：
BACKGROUND: Formal education of oncology is lacking in many undergraduate medical curricula. Mentoring schemes can expose participants to specific areas of medicine and may address the shortfalls in oncology education. Few mentoring schemes have been designed within the United Kingdom, especially within oncology. There is a need to understand reasons for mentor and mentee participation in such schemes and to identify ways to minimize barriers to engagement.
OBJECTIVE: This study identifies motivations for participation in an oncology mentoring scheme and its benefits and limitations to both the mentee and the mentor.
METHODS: The British Oncology Network for Undergraduate Societies launched a National Oncology Mentorship Scheme (NOMS) on September 1, 2021. Mentees (medical student or foundation doctor) were paired with mentors (specialty registrar or consultant), for 6 months of mentoring. In total, 86 mentors and 112 mentees were recruited to the scheme. The mentees and mentors were asked to meet at least 3 times during this period and suggestions were provided on the content of mentoring. Mentees and mentors were invited to complete a prescheme questionnaire, exploring motivations for involvement in the scheme, current experiences within oncology, and knowledge and interests in the field. At the end of the scheme, mentors and mentees were asked to complete a postscheme questionnaire exploring experiences and benefits or limitations of participation. Paired analysis was performed using the Wilcoxon signed-rank test. For free text data, content analysis was applied to summarize the main themes in the data.
RESULTS: Of the 66 (59%) mentees who completed the prescheme questionnaire, 41 (62%) were clinical, 21 (32%) preclinical medical students, and the remainder were junior doctors. For mentees, networking was the primary reason for joining the scheme (n=25, 38%). Mentees ranked experience of oncology at medical school at 3 on 10 (IQR 2-5). In this, 46 (53%) mentors completed the prescheme questionnaire, 35 (76%) were registrar level, and the remainder were consultant level (n=11). The most common reason for mentor participation was to increase awareness and interest in the field (n=29, 63%). Of those who completed the prescheme questionnaire, 23 (35%) mentees and 25 (54%) mentors completed the postscheme questionnaire. Knowledge in all areas of oncology assessed significantly increased during the scheme (P<.001). Most mentees (n=21, 91%) and mentors (n=18, 72%) felt they had benefited from the scheme. Mentees cited gaining insights into oncology as most beneficial; and mentors, opportunities to develop professionally. Whilst mentees did not report any barriers to participating in the scheme, mentors stated lack of time as the greatest barrier to mentoring.
CONCLUSIONS: British Oncology Network for Undergraduate Societies\' NOMS is expanding and is beneficial for mentees through increasing knowledge, providing exposure, and career advice in oncology. Mentors benefit from improving their mentoring skills and personal satisfaction.
OBJECTIVE: This study identifies motivations for participation in an oncology mentoring scheme and its benefits and limitations to both the mentee and the mentor.
METHODS: The British Oncology Network for Undergraduate Societies launched a National Oncology Mentorship Scheme (NOMS) on September 1, 2021. Mentees (medical student or foundation doctor) were paired with mentors (specialty registrar or consultant), for 6 months of mentoring. In total, 86 mentors and 112 mentees were recruited to the scheme. The mentees and mentors were asked to meet at least 3 times during this period and suggestions were provided on the content of mentoring. Mentees and mentors were invited to complete a prescheme questionnaire, exploring motivations for involvement in the scheme, current experiences within oncology, and knowledge and interests in the field. At the end of the scheme, mentors and mentees were asked to complete a postscheme questionnaire exploring experiences and benefits or limitations of participation. Paired analysis was performed using the Wilcoxon signed-rank test. For free text data, content analysis was applied to summarize the main themes in the data.
RESULTS: Of the 66 (59%) mentees who completed the prescheme questionnaire, 41 (62%) were clinical, 21 (32%) preclinical medical students, and the remainder were junior doctors. For mentees, networking was the primary reason for joining the scheme (n=25, 38%). Mentees ranked experience of oncology at medical school at 3 on 10 (IQR 2-5). In this, 46 (53%) mentors completed the prescheme questionnaire, 35 (76%) were registrar level, and the remainder were consultant level (n=11). The most common reason for mentor participation was to increase awareness and interest in the field (n=29, 63%). Of those who completed the prescheme questionnaire, 23 (35%) mentees and 25 (54%) mentors completed the postscheme questionnaire. Knowledge in all areas of oncology assessed significantly increased during the scheme (P<.001). Most mentees (n=21, 91%) and mentors (n=18, 72%) felt they had benefited from the scheme. Mentees cited gaining insights into oncology as most beneficial; and mentors, opportunities to develop professionally. Whilst mentees did not report any barriers to participating in the scheme, mentors stated lack of time as the greatest barrier to mentoring.
CONCLUSIONS: British Oncology Network for Undergraduate Societies\' NOMS is expanding and is beneficial for mentees through increasing knowledge, providing exposure, and career advice in oncology. Mentors benefit from improving their mentoring skills and personal satisfaction.
摘要：
背景：许多本科医学课程缺乏肿瘤学的正规教育。辅导计划可以让参与者接触到特定的医学领域，并可能解决肿瘤学教育的不足。在英国很少设计指导计划，尤其是在肿瘤学领域。有必要了解导师和受训者参与此类计划的原因，并确定将参与障碍降至最低的方法。
目的：本研究确定了参与肿瘤学指导计划的动机及其对受训者和指导者的益处和局限性。
方法：英国肿瘤学本科生协会网络于2021年9月1日启动了国家肿瘤学指导计划（NOMS）。学员（医学生或基础医生）与导师（专业注册官或顾问）配对，6个月的指导。总的来说,该计划招募了86名导师和112名受训者。在此期间，受训者和导师被要求至少见面3次，并就指导内容提供了建议。受训者和导师被邀请完成化疗前问卷，探索参与该计划的动机，目前在肿瘤学领域的经验，以及该领域的知识和兴趣。在计划结束时,导师和受训者被要求完成方案后问卷，探索参与的经验和益处或局限性。使用Wilcoxon符号秩检验进行配对分析。对于自由文本数据，内容分析用于总结数据中的主要主题。
结果：在完成化疗前问卷的66名（59%）受训者中，41例（62%）为临床，21名（32%）临床前医学生，其余的是初级医生。对于受训者，联网是加入该计划的主要原因(n=25，38%)。学员将医学院的肿瘤学经验评为10分之3（IQR2-5）。在此,46名(53%)导师完成了化疗前问卷，35人(76%)是登记员级别，其余为顾问级别(n=11)。导师参与的最常见原因是提高对该领域的认识和兴趣（n=29，63%）。在完成化疗前问卷的人中，23名(35%)受训者和25名(54%)导师完成了方案后问卷。在计划期间评估的所有肿瘤学领域的知识显着增加（P<.001）。大多数受训者（n=21，91％）和导师（n=18，72％）认为他们从该计划中受益。学员们认为获得对肿瘤学的见解是最有益的；和导师，专业发展的机会。虽然受训者没有报告参与该计划的任何障碍，导师认为缺乏时间是指导的最大障碍。
结论：英国肿瘤学本科生协会网络NOMS正在扩大，并且通过增加知识对受训者有利，提供曝光，和肿瘤学的职业建议。导师受益于提高他们的指导技能和个人满意度。
目的：本研究确定了参与肿瘤学指导计划的动机及其对受训者和指导者的益处和局限性。
方法：英国肿瘤学本科生协会网络于2021年9月1日启动了国家肿瘤学指导计划（NOMS）。学员（医学生或基础医生）与导师（专业注册官或顾问）配对，6个月的指导。总的来说,该计划招募了86名导师和112名受训者。在此期间，受训者和导师被要求至少见面3次，并就指导内容提供了建议。受训者和导师被邀请完成化疗前问卷，探索参与该计划的动机，目前在肿瘤学领域的经验，以及该领域的知识和兴趣。在计划结束时,导师和受训者被要求完成方案后问卷，探索参与的经验和益处或局限性。使用Wilcoxon符号秩检验进行配对分析。对于自由文本数据，内容分析用于总结数据中的主要主题。
结果：在完成化疗前问卷的66名（59%）受训者中，41例（62%）为临床，21名（32%）临床前医学生，其余的是初级医生。对于受训者，联网是加入该计划的主要原因(n=25，38%)。学员将医学院的肿瘤学经验评为10分之3（IQR2-5）。在此,46名(53%)导师完成了化疗前问卷，35人(76%)是登记员级别，其余为顾问级别(n=11)。导师参与的最常见原因是提高对该领域的认识和兴趣（n=29，63%）。在完成化疗前问卷的人中，23名(35%)受训者和25名(54%)导师完成了方案后问卷。在计划期间评估的所有肿瘤学领域的知识显着增加（P<.001）。大多数受训者（n=21，91％）和导师（n=18，72％）认为他们从该计划中受益。学员们认为获得对肿瘤学的见解是最有益的；和导师，专业发展的机会。虽然受训者没有报告参与该计划的任何障碍，导师认为缺乏时间是指导的最大障碍。
结论：英国肿瘤学本科生协会网络NOMS正在扩大，并且通过增加知识对受训者有利，提供曝光，和肿瘤学的职业建议。导师受益于提高他们的指导技能和个人满意度。
